{"schema":"hottub-news/story/v1","story":"st_atdpeghepfx5z5hc4koa","title":"신약간 병용요법 사실상 첫 건보 적용…요로상피암 치료","title_en":"New drug combination therapy becomes first health insurance coverage for urothelial carcinoma treatment","outlets":2,"brief":null,"page":"https://hottub.news/stories/new-drug-combination-therapy-becomes-first-health-insurance-coverage-atdpeghepf","count":2,"items":[{"id":"n_xel3vd6ms44va7gi3obq","seq":834343,"kind":"article","title":"신약 간 병용요법에 사실상 첫 건보 적용…요로상피암 치료","title_en":"First insurance coverage for new combination therapy... Treatment for urothelial carcinoma","url":"https://news.sbs.co.kr/news/endPage.do?cooper=RSSREADER&news_id=N1008776850&plink=RSSLINK","summary":"▲ 보건복지부내일부터 서로 다른 제약사가 개발한 신약을 함께 사용하는 병용요법에 사실상 처음으로 건강보험이 적용됩니다.요로상피암 치료…","published":"2026-09-30T05:28:55Z","seen":"2026-09-30T06:04:25Z","lang":"ko","country":"KR","source":{"id":"kite-news-sbs-co-kr-dbe1f7","name":"news.sbs.co.kr","domain":"news.sbs.co.kr"},"via":"kite-news-sbs-co-kr-dbe1f7","topics":["사회","박하정 기자","sbs 뉴스","일반기사","건강보험","병용요법","신약","요로상피암"],"authors":["author"],"entities":[{"id":"Q2501186","name":"transitional cell carcinoma","type":"other"}],"image":"https://img.sbs.co.kr/newimg/news/20260821/202214781.jpg","story":"st_atdpeghepfx5z5hc4koa","category":"health","category_p":0.8500000238418579,"sentiment":"neutral","tone":0.1599999964237213,"political":0.07999999821186066},{"id":"n_atdpeghepfx5z5hc4koa","seq":810235,"kind":"article","title":"신약간 병용요법 사실상 첫 건보 적용…요로상피암 치료","title_en":"New drug combination therapy becomes first health insurance coverage for urothelial carcinoma treatment","url":"https://www.yna.co.kr/view/AKR20260930051300530","summary":"(서울=연합뉴스) 김영신 기자 = 10월부터 서로 다른 제약사가 개발한 신약을 함께 사용하는 병용요법에 사실상 처음으로 건강보험이 적용된다. 요...","published":"2026-09-30T03:00:27Z","seen":"2026-09-30T03:11:09Z","lang":"ko","country":"KR","source":{"id":"kite-yna-co-kr-f0eb60","name":"yna.co.kr","domain":"yna.co.kr","outlet":{"wikidata":"Q333206","name":"Yonhap News Agency","type":"news_agency","country":"KR","designations":["news agency"]}},"via":"kite-yna-co-kr-f0eb60","authors":["김영신"],"entities":[{"id":"Q2501186","name":"transitional cell carcinoma","type":"other"}],"image":"https://img.yna.co.kr/photo/cms/2017/02/07/01/C0A8CA3D0000015A1772A3E30001A030_P2.jpeg","mentions":4,"story":"st_atdpeghepfx5z5hc4koa","category":"health","category_p":0.8500000238418579,"sentiment":"neutral","tone":0.07999999821186066,"political":0.12999999523162842}]}